Genetic polymorphisms of estrogen receptors in Iranian women with diabetes and coronary artery disease

Iranian Journal of Medical Sciences

Volumn 34, Issue 3, 2009, Pages 208-212

  Golkhu, Shekufeh ^a   Ghaedi, Mahboobe ^b   Taghvaie, Narges Mohammad ^b   Boroumand, Mohammad Ali ^c   Davoodi, Gholamreza ^c   Aminzadegan, Alireza ^c   Poorgoli, Leila ^c   Fathollahi, Mahmood Sheikh ^c  

^a ALZAHRA UNIVERSITY   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Coronary artery disease; Diabetes; Estrogen; Estrogen receptor; PvuII; XbaI

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR;

EID: 67749144120     PISSN: 02530716     EISSN: 17353688     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053
2. Zimmet P, Magliano D, Matsuzawa Y, et al. The metabolic syndrome. a global public health problem and a new definition. J Atheroscler Thromb 2005; 12: 295-300.
3. Paik SG, Michelis MA, Kim YT, Shin S. Induction of insulin-dependent diabetes by streptozotocin Inhibition by estrogens and potentiation by androgens. Diabetes 1982; 31: 724-729
4. Bryzgalova G, Gao H, Ahren B, et al. Evidence that oestrogen receptor-alpha plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver. Diabetologia 2006; 49: 588-597 (Pubitemid 43277883)
5. Evangelopoulos D, Alevizaki M, Lekakis J, et al. Molecular analysis of the estrogen receptor α gene in men with coronary artery disease: association with disease status. Clin Chim Acta 2003; 331: 37-44. (Pubitemid 36416610)
6. Maas AH, van der Schouw YT, Grobbee DE, van der Graaf Y. Rise and fall of hormone therapy in postmenopausal women with cardiovascular disease. Menopause 2004; 11: 228-235 (Pubitemid 40353242)
7. Lu H, Higashikata T, Inazu A, et al. Association of estrogen receptor-alpha gene polymorphisms with coronary artery disease in patients with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 2002; 22: 817-823 (Pubitemid 34517795)
8. Mansur Ade P, Nogueira CC, Strunz CM, et al. Genetic polymorphisms of estrogen receptors in patients with premature coronary artery disease. Arch Med Res 2005; 36: 511-517 (Pubitemid 41140058)
9. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. 1999; 16: 442-443
10. Kaplan RC, Heckbert SR, Weiss NS, et al. Postmenopausal estrogens and risk of myocardial infarction in diabetic women. Diabetes Care 1998; 21: 1117-1121 (Pubitemid 28368518)
11. Barrett-Connor E. Sex differences in coronary heart disease: why are women so superior? The 1995 Ancel Keys Lecture. Circulation1997; 95: 252-264
12. Newton KM, LaCroix AZ, Heckbert SR, et al. Estrogen therapy and risk of cardiovascular events among women with type 2 diabetes. Diabetes Care 2003; 26: 2810-2816 (Pubitemid 37205551)
13. Liu J, Zhu H, Zhu X, et al. Estrogen receptor gene polymorphisms and bone mineral density in Chinese postmenopausal women. Chin Med J (Engl) 2003; 116: 364-367 (Pubitemid 36432756)
14. Huang Q, Wang TH, Lu WS, et al. Estrogen receptor alpha gene polymorphism associated with type 2 diabetes mellitus and the serum lipid concentration in Chinese women in Guangzhou. Chin Med J (Engl) 2006; 119: 1794-1801 (Pubitemid 44768609)